JP2011529039A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529039A5
JP2011529039A5 JP2011519256A JP2011519256A JP2011529039A5 JP 2011529039 A5 JP2011529039 A5 JP 2011529039A5 JP 2011519256 A JP2011519256 A JP 2011519256A JP 2011519256 A JP2011519256 A JP 2011519256A JP 2011529039 A5 JP2011529039 A5 JP 2011529039A5
Authority
JP
Japan
Prior art keywords
ultrasound
particles
therapeutic agent
ultrasonic
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011519256A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529039A (ja
JP5689416B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/052449 external-priority patent/WO2010010473A1/en
Publication of JP2011529039A publication Critical patent/JP2011529039A/ja
Publication of JP2011529039A5 publication Critical patent/JP2011529039A5/ja
Application granted granted Critical
Publication of JP5689416B2 publication Critical patent/JP5689416B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011519256A 2008-07-23 2009-06-09 超音波仲介による薬送達 Active JP5689416B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6169008P 2008-07-23 2008-07-23
US61/061,690 2008-07-23
PCT/IB2009/052449 WO2010010473A1 (en) 2008-07-23 2009-06-09 Ultrasound mediated drug delivery

Publications (3)

Publication Number Publication Date
JP2011529039A JP2011529039A (ja) 2011-12-01
JP2011529039A5 true JP2011529039A5 (enExample) 2012-07-26
JP5689416B2 JP5689416B2 (ja) 2015-03-25

Family

ID=40848700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011519256A Active JP5689416B2 (ja) 2008-07-23 2009-06-09 超音波仲介による薬送達

Country Status (5)

Country Link
US (1) US20110125080A1 (enExample)
EP (1) EP2318086B1 (enExample)
JP (1) JP5689416B2 (enExample)
CN (1) CN102112176B (enExample)
WO (1) WO2010010473A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5241714B2 (ja) 2006-07-07 2013-07-17 プロテウス デジタル ヘルス， インコーポレイテッド スマートな非経口送達システム
US9125979B2 (en) 2007-10-25 2015-09-08 Proteus Digital Health, Inc. Fluid transfer port information system
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
EP2531096A4 (en) 2010-02-01 2013-09-11 Proteus Digital Health Inc DATA COLLECTION SYSTEM FOR TWO WRIST
SG182825A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Data gathering system
CN103826692B (zh) * 2011-09-28 2016-06-22 皇家飞利浦有限公司 自动化超声介导递送
JP6313705B2 (ja) * 2011-09-29 2018-04-18 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 重要臓器保護を伴う超音波媒介送達
TWI405583B (zh) * 2011-11-03 2013-08-21 Taipei City Hospital Contrast Agent Enhances the Quantification of Ultrasound in Drug Delivery
CN103055302B (zh) * 2013-01-08 2014-05-14 福建医科大学附属协和医院 一种超声生物效应介导的重组人血管内皮抑制素控释制剂
US20180008534A1 (en) * 2014-12-08 2018-01-11 Robert B. Lomerson Method for preventing, treating, and curing cancer
EP3302443A4 (en) 2015-06-01 2019-02-13 The Trustees Of The University Of Pennsylvania MECHANO SENSITIVE MICRO CAPSULES FOR DRUG DELIVERY
WO2016210136A2 (en) * 2015-06-23 2016-12-29 Advanced Csf Therapies, Llc Methods and system for ultrasonic targeted drug delivery in cystic fluids, such as the cerebrospinal fluid, using buoyancy specific drug carriers
JP7053463B2 (ja) * 2015-11-11 2022-04-12 ナビフス コーポレーション リミテッド 超音波システムを使用して脳腫瘍を治療するための方法及びキット
US11369810B2 (en) * 2016-12-19 2022-06-28 Michalakis Averkiou Method and apparatus for ultrasonic mediation of drug delivery using microbubbles
JP7289061B2 (ja) * 2017-06-29 2023-06-09 インサイテック リミテッド シミュレーションベースの薬物処置計画
US12121597B2 (en) 2018-10-19 2024-10-22 The Board Of Trustees Of The University Of Illinois High-intensity focused ultrasound-induced mechanochemical transduction in synthetic elastomers
US11786215B2 (en) * 2019-01-23 2023-10-17 Washington University Methods of detecting, measuring, or imaging a concentration or location of a therapeutic agent
CA3177232A1 (en) * 2020-06-15 2021-12-23 Bracco Suisse Sa Improvements in ultrasound-mediated therapy
CN112263789B (zh) * 2020-09-18 2025-08-05 北京万孛力医疗器械有限公司 一种调节雄性哺乳动物睾酮水平的装置
WO2025129071A1 (en) * 2023-12-14 2025-06-19 Sonothera, Inc. Methods and systems for improved nucleic acid delivery via ultrasound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1461789A (en) * 1973-04-12 1977-01-19 Lilly Industries Ltd 3-substituted propanoic acid derivatives
US5618275A (en) * 1995-10-27 1997-04-08 Sonex International Corporation Ultrasonic method and apparatus for cosmetic and dermatological applications
US6135971A (en) * 1995-11-09 2000-10-24 Brigham And Women's Hospital Apparatus for deposition of ultrasound energy in body tissue
GB9701237D0 (en) * 1997-01-22 1997-03-12 Nycomed Imaging As Improvements in or relating to contrast agents
US6322532B1 (en) * 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
JP4070339B2 (ja) * 1999-01-20 2008-04-02 ジーイー横河メディカルシステム株式会社 超音波撮像装置
US6712805B2 (en) * 2001-01-29 2004-03-30 Ultra Sonic Tech Llc Method and apparatus for intradermal incorporation of microparticles containing encapsulated drugs using low frequency ultrasound
US6716168B2 (en) 2002-04-30 2004-04-06 Siemens Medical Solutions Usa, Inc. Ultrasound drug delivery enhancement and imaging systems and methods
US7695515B2 (en) 2003-07-15 2010-04-13 Spinal Generations, Llc Spinal disc prosthesis system
CN1909931B (zh) * 2004-01-15 2011-01-12 皇家飞利浦电子股份有限公司 用于分子成像的超声造影剂
US20080019904A1 (en) * 2004-06-29 2008-01-24 Koninklijke Philips Electronics, N.V. System For Manufacturing Micro-Sheres
US8932239B2 (en) 2005-06-07 2015-01-13 Koninklijke Philips N.V. Method and apparatus for ultrasound drug delivery and thermal therapy with phase-convertible fluids
JPWO2008081556A1 (ja) * 2007-01-05 2010-04-30 株式会社島津製作所 超音波装置

Similar Documents

Publication Publication Date Title
JP2011529039A5 (enExample)
Yin et al. Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy
Choi et al. Synergistic local combination of radiation and anti-programmed death ligand 1 immunotherapy using radiation-responsive splintery metallic nanocarriers
JP2023085370A5 (enExample)
Wang et al. Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
Komati et al. Mucoadhesive multiparticulate drug delivery systems: An extensive review of patents
Cavalli et al. Ultrasound-mediated oxygen delivery from chitosan nanobubbles
Wang et al. 5-Aminolevulinic acid–mediated sonodynamic therapy reverses macrophage and dendritic cell passivity in murine melanoma xenografts
EP2133365A3 (en) Compositions and methods for the treatment of infections and tumors
Liang et al. Engineering versatile nanomedicines for ultrasonic tumor immunotherapy
KR20160066554A (ko) 브루톤 타이로신 키나제 억제제 및 면역요법을 이용한 치료
JP2011178784A5 (enExample)
NO20074362L (no) Farmasoytisk preparat inneholdende magnetiske vesikulaere partikler, fremgangsmate for fremstilling av disse, og diagnostisk terapeutisk system
Wu et al. Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy
RU2020109376A (ru) Применение антагонистов рецептора ep4 для лечения nash- ассоциированного рака печени
Cha et al. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma
Do et al. Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing
Kushchayeva et al. Repositioning therapy for thyroid cancer: New insights on established medications
Yang et al. Turning Waste into Wealth: A Potent Sono‐Immune Strategy Based on Microcystis
JP2018515567A5 (enExample)
JP2007517039A5 (enExample)
EP1834646A4 (en) ULTRASONIC CANCER THERAPY ACCELERATOR AND CYTOTOXIC AGENT
Ren et al. Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
WO2016015172A1 (zh) 一种通过纳米材料和外加辐射源实现肿瘤血管阻断的肿瘤治疗方法
JP2019510805A5 (enExample)